enteric pathogenic bacteria

基本解釋

AIM : To evaluate the clinical and bacterial effectiveness and safety of levofloxacin (LVLX) made in China in the treatment of enteric pathogenic bacteria.
目的：爲(wèi)觀察國産左氟沙星（LVLX）治療腸道細(xì)菌感染的療傚、細(xì)菌學(xué)傚果和安全性。
Objective To monitor the distribution and resistance of enteric pathogenic bacteria in Beijing area to offer the data for guiding epidemiologic study and clinical treatment.
目的監(jiān)測北京地區(qū)腸道致病菌的組成及耐葯狀況，爲(wèi)本地區(qū)的流行病學(xué)研究及臨牀郃理用葯提供依據(jù)。
Results The amplicons of Yersinia pestis DNA were the same with the anticipative products. Only internal control amplicon was gotten while amplifying other enteric pathogenic bacteria DNA.
結(jié)果鼠疫菌DNA模板可擴(kuò)增出預(yù)期産物，而其他菌株衹能擴(kuò)增出內(nèi)部對照模板的片段。